For instance, ARNTL2 is significantly upregulated in ccRCC tissues and cell lines, and its high expression is closely associated with clinical stage progression and unfavorable overall survival rates in ccRCC. The gene discussed is BMAL2; the disease is nonpapillary renal cell carcinoma.